April 1, 2024 by Chain Drug Review
Rosacea Awareness Month highlights skin care as new frontier
Pharmacy, Supplier News
CHICAGO – While rosacea sufferers can benefit from prescription medications and procedures to treat the full spectrum of potential signs and symptoms, a growing range of over-the-counter (OTC) skin care products is now available to help achieve optimal results. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public
April 1, 2024 by Chain Drug Review
NACDS promotes three staff in key roles
Leading Headlines, Pharmacy
ARLINGTON, Va. — The National Association of Chain Drug Stores (NACDS) has promoted three staff team members to roles that strategically position NACDS and the industry it serves for the future, ensuring the sustainability of retail health and promoting the viability of pharmacy care services and emerging payment models that are central to the association’s
April 1, 2024 by Chain Drug Review
Upcoming NCPA items for pharmacy teams
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association is pleased to announce these upcoming events for pharmacists and pharmacy team members: April 2 – From Your Shelves to Patient Consumers: Using Front-End Supplies to Market Diabetes Care Services webinar, part of our monthly NCPA Learning Hour series. Patients living with diabetes are more susceptible to kidney disease,
April 1, 2024 by Chain Drug Review
Dollar General promotes 18 executives
Leading Headlines, Retail News
GOODLETTSVILLE, Tenn. — Dollar General has promoted 18 executives to new roles at the company. Leslie Allen has been promoted to senior vice president, human resources. In this role, she will continue to support DG’s store operations team, which now encompasses more than 20,000 retail stores including pOpshelf and Mexico. Throughout her 12-year tenure
March 29, 2024 by Chain Drug Review
Upsher-Smith launches methimazole tablets
Pharmacy, Supplier News
MAPLE GROVE, Minn. – Upsher-Smith Laboratories announced the recent launch of methimazole tablets, USP, 5 mg and 10 mg. The methimazole tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according to IQVIA. The Therapeutic Equivalence (TE) code for the product is AB, and the original Reference Listed Drug (RLD)
March 28, 2024 by Chain Drug Review
Award-winning director Grace Wethor to address 2024 NACDS Annual Meeting
Leading Headlines, Pharmacy
ARLINGTON, Va. – Grace Wethor – an award-winning director, best-selling author, and brain cancer survivor and advocate – is set to speak at the 2024 National Association of Chain Drug Stores (NACDS) Annual Meeting in Palm Beach, FL. Wethor will present during the NACDS Luncheon on Monday, April 29. After being told she had six months to
March 28, 2024 by Chain Drug Review
U.S. News reveals the 2024 Best OTC Medicine & Health Products
Leading Headlines, Retail News, Supplier News
WASHINGTON – U.S. News & World Report, the global authority in health care rankings and consumer advice, today published the second annual Best OTC Medicine & Health Products. The latest edition of the rankings features 132 categories, with 33 brand new over-the-counter product categories included this year. The brands with the most No. 1 products
March 28, 2024 by Chain Drug Review
LexisNexis Risk Solutions releases new fraud study
Leading Headlines, Supplier News
ATLANTA — LexisNexis Risk Solutions has revealed the findings of the fourteenth edition of its annual LexisNexis True Cost of Fraud Study: Ecommerce and Retail Report – U.S. and Canada Edition. The report, based on a commissioned survey conducted by Forrester Consulting, shows that merchants in the U.S. and Canada incur an average cost of
March 28, 2024 by Chain Drug Review
Rite Aid nears creditor deal to avoid liquidation
Leading Headlines, Retail News
PHILADELPHIA — Rite Aid Corp. is nearing a deal with key bondholders and other creditor groups that will allow the pharmacy chain to avoid a liquidation, according to published reports. The deal calls for junior bondholders to take over the struggling pharmacy chain and exit Chapter 11 protection as a going concern, according to the
March 27, 2024 by Chain Drug Review
Bridges Consumer Healthcare names Speranza new CEO
Supplier News
CHATTANOOGA, Tenn. — Bridges Consumer Healthcare, a consumer health care company focused on over-the-counter and personal care products, today announced the appointment of John Speranza as CEO. Speranza succeeds Robert Long, who has led the company since its formation in 2020. With deep industry experience in scaling and marketing consumer brands, Speranza most recently served
March 27, 2024 by Chain Drug Review
CVS invests more than $3M in organizations improving health outcomes in Phoenix
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health announced more than $3 million in new grants to support organizations in Phoenix working to increase equitable access to health care, address social determinants of health and educate the community on the effects of air pollution. This announcement was made during a Project Health event in Phoenix and included CVS Health leaders, community organizations and local officials.
March 27, 2024 by Chain Drug Review
Rolaids teams with Lil’ Drug Store Products
Leading Headlines, Supplier News
CEDAR RAPIDS, Iowa — Lil’ Drug Store Products (LDSP) announces a strategic partnership with Procter & Gamble (P&G) for the preferred distribution of Rolaids – the trusted heartburn relief brand – to convenience and travel retailers nationwide. Following P&G’s acquisition of Rolaids, LDSP has emerged as the primary distributor, leading the reintroduction of its diverse product range into key
March 27, 2024 by Chain Drug Review
Study Reveals U.S. Retailers' Shift Towards Customer-Centric Retail Media Networks
Leading Headlines, Retail News
NEW YORK – Getting closer to their own customers was key for 41% of retailers when evolving their Retail Media Network (RMN) capabilities, the latest research from ADvendio, the leading omnichannel advertising solution provider, has shown. Original research of over 50 senior U.S. retailers, spanning ecommerce, marketing and retail media professionals revealed that, despite the sizable revenue
March 26, 2024 by Chain Drug Review
mifepristone
Leading Headlines
WASHINGTON — A majority of Supreme Court justices appeared skeptical Tuesday of the idea of a nationwide ban or new limits on mifepristone, the primary drug used for medication abortions. The case was the first abortion-related hearing since the court reversed Roe v. Wade and the proceedings at time went into detail of the process and